ascopubs.org

A retrospective observational study to evaluate the efficacy of trifluridine/tipiracil ± bevacizumab in metastatic colorectal cancer with MSI-high/deficient MMR.

Fruquintinib combined with FOLFIRI/mFOLFOX6 as second-line treatment in patients with RAS-mutant metastatic colorectal cancer (mCRC): A multicenter, open-label, phase II study. This is an ASCO Meeting ...
ascopubs.org

Retrospective, observational study to describe the clinical characteristics, management, and outcomes of bispecific anti-gprc5d antibody in patients with relapsed refractory ...

Outcomes with non-BCMA CAR T cell therapy for multiple myeloma: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...